Readings Newsletter
Become a Readings Member to make your shopping experience even easier.
Sign in or sign up for free!
You’re not far away from qualifying for FREE standard shipping within Australia
You’ve qualified for FREE standard shipping within Australia
The cart is loading…
This title is printed to order. This book may have been self-published. If so, we cannot guarantee the quality of the content. In the main most books will have gone through the editing process however some may not. We therefore suggest that you be aware of this before ordering this book. If in doubt check either the author or publisher’s details as we are unable to accept any returns unless they are faulty. Please contact us if you have any questions.
It is not uncommon for experts in healthcare, bioengineering and the life sciences to lack familiarity with the fundamental principles of commerce and finance. Conversely, those responsible for financial decisions may lack familiarity with the intricacies of biomedical research and development processes.
'Navigating the Business Side of Biomedicine and Biotechnology' serves as an interdisciplinary bridge between these two sectors, offering an introductory exploration of the role played by the finance and business world in biotechnological healthcare delivery and drug development.
By focusing on the interplay between scientific advancements, business models and financial frameworks, the author presents industry-specific terminologies and dynamics, thereby consolidating the nature of the interaction. The ten chapters of the book address specific financial concepts and their applications within the biomedical and healthcare industries.
The necessity for 'Navigating the Business Side of Biomedicine and Biotechnology' arises from its consideration of the ongoing advancements in biotechnology, the industry's requirement for alternative business models and the challenges surrounding patient access.
The intended audience for this publication includes those seeking to gain an understanding of the complexities of healthcare finance, biomedical experts seeking to comprehend the financial foundations of their field, other professionals in healthcare management and pharmaceuticals, researchers, regulators, policymakers, lawyers, patient advocates, patients, philanthropists and trade associations.
ABSTRACTING & INDEXING
Baidu Scholar Bayerische Staatsbibliothek BDS BoD Bowker Book Data Ciando CNKI Scholar (China National Knowledge Infrastructure) Dimensions EBSCO ExLibris Google?Books Google Scholar Naviga ReadCube Semantic?Scholar? TDOne?(TDNet) WorldCat?(OCLC) X-MOL
$9.00 standard shipping within Australia
FREE standard shipping within Australia for orders over $100.00
Express & International shipping calculated at checkout
This title is printed to order. This book may have been self-published. If so, we cannot guarantee the quality of the content. In the main most books will have gone through the editing process however some may not. We therefore suggest that you be aware of this before ordering this book. If in doubt check either the author or publisher’s details as we are unable to accept any returns unless they are faulty. Please contact us if you have any questions.
It is not uncommon for experts in healthcare, bioengineering and the life sciences to lack familiarity with the fundamental principles of commerce and finance. Conversely, those responsible for financial decisions may lack familiarity with the intricacies of biomedical research and development processes.
'Navigating the Business Side of Biomedicine and Biotechnology' serves as an interdisciplinary bridge between these two sectors, offering an introductory exploration of the role played by the finance and business world in biotechnological healthcare delivery and drug development.
By focusing on the interplay between scientific advancements, business models and financial frameworks, the author presents industry-specific terminologies and dynamics, thereby consolidating the nature of the interaction. The ten chapters of the book address specific financial concepts and their applications within the biomedical and healthcare industries.
The necessity for 'Navigating the Business Side of Biomedicine and Biotechnology' arises from its consideration of the ongoing advancements in biotechnology, the industry's requirement for alternative business models and the challenges surrounding patient access.
The intended audience for this publication includes those seeking to gain an understanding of the complexities of healthcare finance, biomedical experts seeking to comprehend the financial foundations of their field, other professionals in healthcare management and pharmaceuticals, researchers, regulators, policymakers, lawyers, patient advocates, patients, philanthropists and trade associations.
ABSTRACTING & INDEXING
Baidu Scholar Bayerische Staatsbibliothek BDS BoD Bowker Book Data Ciando CNKI Scholar (China National Knowledge Infrastructure) Dimensions EBSCO ExLibris Google?Books Google Scholar Naviga ReadCube Semantic?Scholar? TDOne?(TDNet) WorldCat?(OCLC) X-MOL